Evidence map›Paper›PMID 29855491›Full record

ArticleScientific reports2018

Ameliorative effect of Sedum sarmentosum Bunge extract on Tilapia fatty liver via the PPAR and P53 signaling pathway.

Lida Huang, Yuan Cheng, Kai Huang, Yu Zhou, Yanqun Ma, Mengci Zhang

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Dietary nano-selenium alleviated intestinal damage of juvenile grass carp (Animal nutrition (Zhongguo xu mu shou yi xue hui) · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Journal of healthcare engineering · 2021
    Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Lida HuangCollege of Animal Science and Technology of Guangxi University, Nanning, China.
Yuan ChengCollege of Animal Science and Technology of Guangxi University, Nanning, China.
Kai HuangCollege of Animal Science and Technology of Guangxi University, Nanning, China. kaihuangnn1@163.com.
Yu ZhouGuangxi Academy of Fishery Sciences, Nanning, China. zy123000@qq.com.
Yanqun MaCollege of Animal Science and Technology of Guangxi University, Nanning, China.
Mengci ZhangCollege of Animal Science and Technology of Guangxi University, Nanning, China.
Guangxi University · CNGuangxi Academy of Fishery Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fatty liver disease is a growing problem in fish aquaculture and there is an urgent need to identify causes and possible remedies. In the present study, the effects of treating fatty liver disease in the Nile tilapia (Oreochromis niloticus Linnaeus, 1758) with an extract derived from a herb, Sedum sarmentosum Bunge (SSB), was investigated. We found that the SSB extract could restore the changes to feed coefficient, immune capacity, and pathological index caused by fatty liver disease, and also prevent apoptosis in hepatocytes. An RNA-seq analysis showed that treatment with SSB extract altered expression of genes in the lipid metabolic process, metabolic process, and oxidation-reduction process. Our results suggest that disorders of the PPAR and p53 signaling pathways may be involved in steatohepatitis development and in the therapeutic mechanism of the SSB extract treatment; these observations shed new light on possible treatment of steatohepatitis.

Indexed as

AnimalsAntioxidantsApoptosisCichlidsDietFatty LiverFish DiseasesGene Expression RegulationHepatocytesLipid MetabolismLiverPeroxisome Proliferator-Activated ReceptorsPlant ExtractsProtective AgentsSedumSignal TransductionAntioxidantsPeroxisome Proliferator-Activated ReceptorsPlant ExtractsProtective AgentsTumor Suppressor Protein p53

Identifiers

PMID29855491
PMCPMC5981579
OpenAlexW2806510041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.